MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048975 A) filed by Eli Lilly And Company, Indianapolis, on May 21, for 'glucagon-like peptide 1 receptor agonists.'
Inventor(s) include Bauer, Renato Alejandro; Buchanan, Travis Lamonte; Chen, Qi; Cumming, Graham Robert; Hergueta, Antonio Rodriguez; and Woerly, Eric Michael.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "In an embodiment, the present invention provides a compound of the formula: or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus."
The patent application ...